Emoxipine
CAS No. 2364-75-2
Emoxipine ( 2-ETHYL-3-HYDROXY-6-METHYLPYRIDINE )
产品货号. M22196 CAS No. 2364-75-2
埃莫西平是一种抗抑郁药。埃莫西平(2-乙基-6-甲基-3-羟基吡啶盐酸盐)和美西多(2-乙基-6-甲基-3-羟基吡啶琥珀酸盐)对外周血脂质过氧化产物含量的影响研究了中老年腹主动脉粥样硬化患者胃肠道病理临床症状的动态变化。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥273 | 有现货 |
|
| 10MG | ¥406 | 有现货 |
|
| 25MG | ¥684 | 有现货 |
|
| 50MG | ¥1014 | 有现货 |
|
| 100MG | ¥1485 | 有现货 |
|
| 200MG | ¥2223 | 有现货 |
|
| 500MG | ¥3762 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥186 | 有现货 |
|
生物学信息
-
产品名称Emoxipine
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述埃莫西平是一种抗抑郁药。埃莫西平(2-乙基-6-甲基-3-羟基吡啶盐酸盐)和美西多(2-乙基-6-甲基-3-羟基吡啶琥珀酸盐)对外周血脂质过氧化产物含量的影响研究了中老年腹主动脉粥样硬化患者胃肠道病理临床症状的动态变化。
-
产品描述Emoxipine is an antidepressant agent.The influence of emoxipine (2-ethyl-6-methyl-3-hydroxypyridine hydrochloride) and mexidol (2-ethyl-6-methyl-3-hydroxypyridine succinate) on the content of lipid peroxidation products in peripheral blood and the dynamics of clinical symptoms of gastrointestinal tract pathology has been studied in patients of middle and senile age with atherosclerosis in the abdominal aorta.?It is established that a two-week 3-hydroxypyridine derivatives leads to a decrease in the level of lipid peroxidation products.?The administration of emoxipine led to the most pronounced control of pain.
-
体外实验——
-
体内实验——
-
同义词2-ETHYL-3-HYDROXY-6-METHYLPYRIDINE
-
通路Others
-
靶点Other Targets
-
受体antidepressant
-
研究领域——
-
适应症——
化学信息
-
CAS Number2364-75-2
-
分子量137.18
-
分子式C8H11NO
-
纯度>98% (HPLC)
-
溶解度——
-
SMILESCCc1nc(C)ccc1O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
-
4-Methylumbelliferyl...
4-Methylumbelliferyl-β-D-xylopyranoside (MuX) 可作为 β- 木糖苷酶活性研究的底物。4-Methylumbelliferyl-β-D-xylopyranoside 表现出爆裂的稳态动力学,这支持底物4-Methylumbelliferyl-β-D-xylopyranoside 糖苷键快速水解的结论。
-
3-Hydroxytectoridin
3'-Hydroxytectoridin is a flavonoid that can be isolated from Belamcandae Rhizoma.
-
Nogo-66 (1-40)
Peptide fragment corresponding to residues 1 - 40 of Nogo-66, the domain of the myelin protein Nogo that inhibits axonal outgrowth. Acts as a competitive antagonist at the Nogo-66 receptor (NgR); blocks Nogo-66- and CNS myelin-induced inhibition of axonal growth, but does not reduce myelin-associated glycoprotein (MAG) inhibition of neurite outgrowth in vitro. Promotes regeneration of hemisected spinal axons and locomotor recovery following spinal injury in vivo.
021-51111890
购物车()
sales@molnova.cn

